Background : Bendamustine, a bifunctional alkylating agent with anticipated purin-like properties is active in metastatic breast cancer (MBC) patients.
The catalysts on studying can divide into two kinds: the transition metal bifunctional catalysts and the nitride, carbide and oxycarbide catalysts of transition metals.